Genetic Modifiers of Conduction Disease Risk in Myotonic Dystrophy

Principal Investigator: Saman Nazarian

Co-Principal Investigator: Kathryn Wagner

This multi-center case controlled observational study is established to determine if genetic variants that are known to modulate cardiac conduction and arrhythmia risk in the general population are associated with risk of ECG abnormalities in myotonic dystrophy. Patients with type I myotonic dystrophy with or without electrocardiographic abnormalities will be recruited. Blood samples will be collected for focused genetic analysis.